MetaCap

Palisade Bio Insider Trades

NASDAQ: PALIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.54+0.09 (+6.21%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
10 · $296.74K
Sales
4 · $420.18K
Shares bought / sold
155.00K / 204.56K
Net activity
Net selling $123,440

Palisade Bio insider activity

Over the last 12 months, Palisade Bio insiders reported 33 transactions on SEC Form 4: 10 open-market purchases and 4 sales. Insiders bought $296,738 and sold $420,178 worth of stock, for net insider selling of $123,440. The largest seller was Finley John David, with $310,161 in reported sales.

The most recent filing shows Finley John David (CEO CFO) reporting a transaction in 3,227,384 shares on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PALI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PALI insider transactions

Palisade Bio insider transactions
DateInsiderTypeSharesValueFiling
Oct 6, 2026Jones Mitchell LawrenceSee RemarksTax withholding1,031,102$1.54MForm 4
Oct 6, 2026Jones Mitchell LawrenceSee RemarksOption exercise2,620,850—Form 4
Oct 6, 2026Finley John DavidCEO CFOTax withholding1,411,982$2.10MForm 4
Oct 6, 2026Finley John DavidCEO CFOOption exercise3,227,384—Form 4
Oct 2, 2026Williams Donald AllenDirectorBuy10,000$14.60KForm 4
Oct 1, 2026Williams Donald AllenDirectorBuy10,000$14.20KForm 4
Aug 19, 2026Finley John DavidCEO, CFOGift88,400—Form 4
Aug 19, 2026Finley John DavidCEO, CFOGift88,400—Form 4
Jul 9, 2026Baltera Robert Jr.DirectorBuy25,000$48.90KForm 4
Jul 8, 2026Baltera Robert Jr.DirectorBuy20,000$39.80KForm 4
Jul 7, 2026Finley John DavidCEO, CFOOption exercise133$93.10Form 4
Jul 7, 2026Finley John DavidCEO, CFOSale146,798$303.34KForm 4
Jul 7, 2026Baltera Robert Jr.DirectorBuy30,000$61.04KForm 4
Jul 7, 2026Jones Mitchell LawrenceChief Medical OfficerSale51,880$106.54KForm 4
Jul 6, 2026Finley John DavidCEO, CFOOption exercise335,167—Form 4
Jul 6, 2026Baltera Robert Jr.DirectorBuy20,000$41.04KForm 4
Jul 6, 2026Jones Mitchell LawrenceChief Medical OfficerOption exercise131,167—Form 4
Jul 2, 2026Baltera Robert Jr.DirectorBuy10,000$19.80KForm 4
Jul 1, 2026Baltera Robert Jr.DirectorBuy20,000$39.60KForm 4
Jun 10, 2026Zwick Jordan MichaelDirectorAward336,904—Form 4
Jun 10, 2026Wei BinxianDirectorOption exercise20,200—Form 4
Jun 10, 2026Wei BinxianDirectorAward592,300—Form 4
Jun 10, 2026Chuang EmilDirectorOption exercise20,200—Form 4
Jun 10, 2026Chuang EmilDirectorAward592,300—Form 4
Jun 10, 2026Williams Donald AllenDirectorOption exercise60,666—Form 4
Jun 10, 2026Williams Donald AllenDirectorAward1,498,900—Form 4
Jun 10, 2026Baltera Robert Jr.DirectorAward336,904—Form 4
Feb 12, 2026Finley John DavidCEO, CFOSale3,896$6.82KForm 4
Feb 12, 2026Jones Mitchell LawrenceChief Medical OfficerSale1,989$3.48KForm 4
Feb 11, 2026Finley John DavidCEO, CFOOption exercise13,333—Form 4
Feb 11, 2026Jones Mitchell LawrenceChief Medical OfficerOption exercise8,000—Form 4
Jan 16, 2026Williams Donald AllenDirectorBuy5,000$8.36KForm 4
Jan 9, 2026Williams Donald AllenDirectorBuy5,000$9.40KForm 4
Nov 21, 2024Williams Donald AllenDirectorOption exercise388—Form 4
Nov 21, 2024Wei BinxianDirectorOption exercise388—Form 4
Jun 11, 2024Wei BinxianDirectorOption exercise465—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related